pMKO.1 puro Rb shRNA Citations (4)
Originally described in: Transformation of human and murine fibroblasts without viral oncoproteins.Boehm JS, Hession MT, Bulmer SE, Hahn WC Mol Cell Biol. 2005 Aug . 25(15):6464-74. PubMed Journal
Articles Citing pMKO.1 puro Rb shRNA
Articles |
---|
Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex. Kumar P P, Emechebe U, Smith R, Franklin S, Moore B, Yandell M, Lessnick SL, Moon AM. Elife. 2014 May 29;3. doi: 10.7554/eLife.02805. PubMed |
A basal level of DNA damage and telomere deprotection increases the sensitivity of cancer cells to G-quadruplex interactive compounds. Salvati E, Rizzo A, Iachettini S, Zizza P, Cingolani C, D'Angelo C, Porru M, Mondello C, Aiello A, Farsetti A, Gilson E, Leonetti C, Biroccio A. Nucleic Acids Res. 2015 Feb 18;43(3):1759-69. doi: 10.1093/nar/gkv006. Epub 2015 Jan 23. PubMed |
Nuclear Envelope Rupture Is Enhanced by Loss of p53 or Rb. Yang Z, Maciejowski J, de Lange T. Mol Cancer Res. 2017 Nov;15(11):1579-1586. doi: 10.1158/1541-7786.MCR-17-0084. Epub 2017 Aug 15. PubMed |
CRISPR/Cas9 treatment causes extended TP53-dependent cell cycle arrest in human cells. Geisinger JM, Stearns T. Nucleic Acids Res. 2020 Sep 18;48(16):9067-9081. doi: 10.1093/nar/gkaa603. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.